Study to understand the effectiveness and safety of Injection Sepsivac in the patients of Gram negative sepsis
Phase 4
- Conditions
- Health Condition 1: A415- Sepsis due to other Gram-negativeorganisms
- Registration Number
- CTRI/2020/12/029825
- Lead Sponsor
- Apollo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed to have sepsis due to gram negative organisms (clinical diagnosis)
Exclusion Criteria
Pregnant patients, patients of sepsis with other organism than gram negative, patient <18 years and >65 years, patients not willing to provide consent
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method all-cause mortality <br/ ><br>Timepoint: 28 days
- Secondary Outcome Measures
Name Time Method Days on ventilator and vasopressor, Intensive Care Unit length of stay, Change in SOFA score, To monitor adverse eventsTimepoint: 3, 7, 14, 28 days